What is VRAX's gross margin?

Virax (VRAX) has a gross margin of 62% and a net margin of -40439%.

What is VRAX's P/E ratio?

Track Virax (VRAX) P/E ratio, ROE, and valuation metrics over time.

Where can I see VRAX's full financials?

See Virax (VRAX) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Virax (VRAX) Financials — Revenue, Earnings, Cash Flow

$2.20

-0.04 (-1.79%)

Weekly Expected Move ±9.1%

$2 $2 $2 $2 $3

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $410575 mcap · 20M float · 7.12% daily turnover · Short 31% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$0M

Revenue

-87.7% YoY

$-13M

Net Income

-10.1% YoY

$-13M

Free Cash Flow

-11.4% YoY

61.9%

Gross Margin

-51515.2%

Op. Margin

-40439.1%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-207.4%

ROA-194.4%

ROIC-812.1%

Valuation

P/E-0.1

P/B0.1

EV/EBITDA0.4

Leverage

Debt/Equity0.05

Current Ratio9.97

Interest Cov.-96.9x

Quality Scores

Piotroski F4/9

Altman Z-9.83

Beneish M-6.11